Morpholino oligonucleotides do not participate perfectly in standard Watson-Crick complexes with RNA

Gaoping Xiao, Donna Wesolowski, Mina Izadjoo, Sidney Altman

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

RNase P from E. coli will cleave a RNA at a site designated in a complex with an external guide sequence (EGS). The location of the site is determined by the Watson-Crick complementary sequence that can be formed between the RNA and the EGS. Morpholino oligonucleotides (PMOs) that have the same base sequences as any particular EGS will not direct cleavage by RNase P of the target RNA at the expected site in three mRNAs. Instead, cleavage occurs at a secondary site that does not correspond exactly to the expected Watson-Crick sequence in the PMO. This cleavage in the mRNA for a drug resistance gene, CAT mRNA, is at least second order in the concentration of the PMOs, but the mechanism is not understood yet and might be more complicated than a simple second-order reaction. EGSs and PMOs inhibit the reactions of each other effectively in a competitive fashion. A basic peptide attached to the PMO (PPMO) is more effective because of its binding properties to the mRNA as a substrate. However, a PMO is just as efficient as a PPMO on a mRNA that is mutated so that the canonical W-C site has been altered. The altered mRNA is not recognizable by effective extensive W-C pairing to an EGS or PMO. The complex of a PMO on a mutated mRNA as a substrate shows that the dimensions of the modified oligonucleotide cannot be the same as a naked piece of single-stranded RNA.

Original languageEnglish (US)
Pages (from-to)2218-2225
Number of pages8
JournalRNA
Volume16
Issue number11
DOIs
StatePublished - Nov 2010
Externally publishedYes

Fingerprint

Morpholinos
RNA
Messenger RNA
Ribonuclease P
Guide RNA
Drug Resistance
Oligonucleotides
Escherichia coli
Peptides
Genes

Keywords

  • Drug resistance
  • EGS
  • mRNA
  • RNase P

ASJC Scopus subject areas

  • Molecular Biology

Cite this

Morpholino oligonucleotides do not participate perfectly in standard Watson-Crick complexes with RNA. / Xiao, Gaoping; Wesolowski, Donna; Izadjoo, Mina; Altman, Sidney.

In: RNA, Vol. 16, No. 11, 11.2010, p. 2218-2225.

Research output: Contribution to journalArticle

Xiao, Gaoping ; Wesolowski, Donna ; Izadjoo, Mina ; Altman, Sidney. / Morpholino oligonucleotides do not participate perfectly in standard Watson-Crick complexes with RNA. In: RNA. 2010 ; Vol. 16, No. 11. pp. 2218-2225.
@article{a37627dedaf74c598ea512b46297bfd5,
title = "Morpholino oligonucleotides do not participate perfectly in standard Watson-Crick complexes with RNA",
abstract = "RNase P from E. coli will cleave a RNA at a site designated in a complex with an external guide sequence (EGS). The location of the site is determined by the Watson-Crick complementary sequence that can be formed between the RNA and the EGS. Morpholino oligonucleotides (PMOs) that have the same base sequences as any particular EGS will not direct cleavage by RNase P of the target RNA at the expected site in three mRNAs. Instead, cleavage occurs at a secondary site that does not correspond exactly to the expected Watson-Crick sequence in the PMO. This cleavage in the mRNA for a drug resistance gene, CAT mRNA, is at least second order in the concentration of the PMOs, but the mechanism is not understood yet and might be more complicated than a simple second-order reaction. EGSs and PMOs inhibit the reactions of each other effectively in a competitive fashion. A basic peptide attached to the PMO (PPMO) is more effective because of its binding properties to the mRNA as a substrate. However, a PMO is just as efficient as a PPMO on a mRNA that is mutated so that the canonical W-C site has been altered. The altered mRNA is not recognizable by effective extensive W-C pairing to an EGS or PMO. The complex of a PMO on a mutated mRNA as a substrate shows that the dimensions of the modified oligonucleotide cannot be the same as a naked piece of single-stranded RNA.",
keywords = "Drug resistance, EGS, mRNA, RNase P",
author = "Gaoping Xiao and Donna Wesolowski and Mina Izadjoo and Sidney Altman",
year = "2010",
month = "11",
doi = "10.1261/rna.2256610",
language = "English (US)",
volume = "16",
pages = "2218--2225",
journal = "RNA",
issn = "1355-8382",
publisher = "Cold Spring Harbor Laboratory Press",
number = "11",

}

TY - JOUR

T1 - Morpholino oligonucleotides do not participate perfectly in standard Watson-Crick complexes with RNA

AU - Xiao, Gaoping

AU - Wesolowski, Donna

AU - Izadjoo, Mina

AU - Altman, Sidney

PY - 2010/11

Y1 - 2010/11

N2 - RNase P from E. coli will cleave a RNA at a site designated in a complex with an external guide sequence (EGS). The location of the site is determined by the Watson-Crick complementary sequence that can be formed between the RNA and the EGS. Morpholino oligonucleotides (PMOs) that have the same base sequences as any particular EGS will not direct cleavage by RNase P of the target RNA at the expected site in three mRNAs. Instead, cleavage occurs at a secondary site that does not correspond exactly to the expected Watson-Crick sequence in the PMO. This cleavage in the mRNA for a drug resistance gene, CAT mRNA, is at least second order in the concentration of the PMOs, but the mechanism is not understood yet and might be more complicated than a simple second-order reaction. EGSs and PMOs inhibit the reactions of each other effectively in a competitive fashion. A basic peptide attached to the PMO (PPMO) is more effective because of its binding properties to the mRNA as a substrate. However, a PMO is just as efficient as a PPMO on a mRNA that is mutated so that the canonical W-C site has been altered. The altered mRNA is not recognizable by effective extensive W-C pairing to an EGS or PMO. The complex of a PMO on a mutated mRNA as a substrate shows that the dimensions of the modified oligonucleotide cannot be the same as a naked piece of single-stranded RNA.

AB - RNase P from E. coli will cleave a RNA at a site designated in a complex with an external guide sequence (EGS). The location of the site is determined by the Watson-Crick complementary sequence that can be formed between the RNA and the EGS. Morpholino oligonucleotides (PMOs) that have the same base sequences as any particular EGS will not direct cleavage by RNase P of the target RNA at the expected site in three mRNAs. Instead, cleavage occurs at a secondary site that does not correspond exactly to the expected Watson-Crick sequence in the PMO. This cleavage in the mRNA for a drug resistance gene, CAT mRNA, is at least second order in the concentration of the PMOs, but the mechanism is not understood yet and might be more complicated than a simple second-order reaction. EGSs and PMOs inhibit the reactions of each other effectively in a competitive fashion. A basic peptide attached to the PMO (PPMO) is more effective because of its binding properties to the mRNA as a substrate. However, a PMO is just as efficient as a PPMO on a mRNA that is mutated so that the canonical W-C site has been altered. The altered mRNA is not recognizable by effective extensive W-C pairing to an EGS or PMO. The complex of a PMO on a mutated mRNA as a substrate shows that the dimensions of the modified oligonucleotide cannot be the same as a naked piece of single-stranded RNA.

KW - Drug resistance

KW - EGS

KW - mRNA

KW - RNase P

UR - http://www.scopus.com/inward/record.url?scp=78149356304&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78149356304&partnerID=8YFLogxK

U2 - 10.1261/rna.2256610

DO - 10.1261/rna.2256610

M3 - Article

VL - 16

SP - 2218

EP - 2225

JO - RNA

JF - RNA

SN - 1355-8382

IS - 11

ER -